These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26908731)

  • 1. Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B.
    Aragri M; Alteri C; Battisti A; Di Carlo D; Minichini C; Sagnelli C; Bellocchi MC; Pisaturo MA; Starace M; Armenia D; Carioti L; Pollicita M; Salpini R; Sagnelli E; Perno CF; Coppola N; Svicher V
    J Infect Dis; 2016 Jun; 213(12):1897-905. PubMed ID: 26908731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
    Colagrossi L; Hermans LE; Salpini R; Di Carlo D; Pas SD; Alvarez M; Ben-Ari Z; Boland G; Bruzzone B; Coppola N; Seguin-Devaux C; Dyda T; Garcia F; Kaiser R; Köse S; Krarup H; Lazarevic I; Lunar MM; Maylin S; Micheli V; Mor O; Paraschiv S; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Simon F; Stanojevic M; Stene-Johansen K; Tihic N; Trimoulet P; Verheyen J; Vince A; Lepej SZ; Weis N; Yalcinkaya T; Boucher CAB; Wensing AMJ; Perno CF; Svicher V;
    BMC Infect Dis; 2018 Jun; 18(1):251. PubMed ID: 29859062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
    Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.
    Yamani LN; Yano Y; Utsumi T; Juniastuti ; Wandono H; Widjanarko D; Triantanoe A; Wasityastuti W; Liang Y; Okada R; Tanahashi T; Murakami Y; Azuma T; Soetjipto ; Lusida MI; Hayashi Y
    J Clin Microbiol; 2015 Oct; 53(10):3165-75. PubMed ID: 26202119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
    J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
    Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
    Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection.
    Eschlimann M; Malvé B; Velay A; Fenaux H; Berger S; Frippiat JP; Zoulim F; Bensenane M; Bronowicki JP; Goehringer F; May T; Jeulin H; Schvoerer E
    J Clin Virol; 2017 Sep; 94():115-122. PubMed ID: 28822954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.
    Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP;
    J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors.
    Harris BJ; Holzmayer V; Qureshi H; Khan MA; Khan SA; Salamat N; Jafri S; Brennan CA
    PLoS One; 2017; 12(6):e0178988. PubMed ID: 28582431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of Mutations in the Reverse Transcriptase and Overlapping Surface Genes of Hepatitis B Virus (HBV) in Treatment-Naïve Indonesian HBV Carriers.
    Yamani LN; Yano Y; Utsumi T; Wasityastuti W; Rinonce HT; Widasari DI; Juniastuti ; Lusida MI; Soetjipto ; Hayashi Y
    Jpn J Infect Dis; 2017 Nov; 70(6):647-655. PubMed ID: 29093313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of mutations in hepatitis B virus surface and polymerase genes isolated from treatment-naïve Nigerians infected with genotype E.
    Olusola BA; Faneye AO; Oluwasemowo OO; Motayo BO; Adebayo S; Oludiran-Ayoade AE; Aleru B; George UE; Oragwa AO
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33704041
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies.
    Zhou TC; Li X; Li L; Li XF; Zhang L; Wei J
    Sci Rep; 2017 Apr; 7(1):661. PubMed ID: 28386078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
    Cavallone D; Ricco G; Oliveri F; Colombatto P; Moriconi F; Coco B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1406-1416. PubMed ID: 32390175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.
    Solmone M; Vincenti D; Prosperi MC; Bruselles A; Ippolito G; Capobianchi MR
    J Virol; 2009 Feb; 83(4):1718-26. PubMed ID: 19073746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
    Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
    J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new vaccine escape mutant of hepatitis B virus causes occult infection.
    Ye Q; Shang SQ; Li W
    Hum Vaccin Immunother; 2015; 11(2):407-10. PubMed ID: 25692622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development.
    Svicher V; Cento V; Salpini R; Mercurio F; Fraune M; Beggel B; Han Y; Gori C; Wittkop L; Bertoli A; Micheli V; Gubertini G; Longo R; Romano S; Visca M; Gallinaro V; Marino N; Mazzotta F; De Sanctis GM; Fleury H; Trimoulet P; Angelico M; Cappiello G; Zhang XX; Verheyen J; Ceccherini-Silberstein F; Perno CF
    Dig Liver Dis; 2011 Dec; 43(12):975-83. PubMed ID: 21831732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot.
    Sumer U; Sayan M
    Pol J Microbiol; 2019 Dec; 68(4):449-456. PubMed ID: 31880889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.